Nanotechnology enterprise NanoInk Inc. announced the launch of its new NanoBioDiscovery Div., which will focus on novel technologies for biomarker and drug discovery. Located in Skokie, Ill., NanoInk’s new division will utilize dip-pen nanolithography nanofabrication techniques, in combination with proprietary detection systems, to produce uniquely sensitive assays for protein discovery and identification. Femtofluidics handling of samples and reagents with these systems will help provide key benefits for users, including enhanced reaction kinetics and assay cost savings, NanoInk said.